Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 3/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.34 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
| ▸ | CHEK1 | O14757 | 5/20 | 0.32 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21885094 | 1.00 | SLC6A2 (0.38) | SLC6A2MAPK14IMPDH2MKNK1HSD17B1 | |
| SCHEMBL21885053 | 0.96 | SLC6A2 (0.38) | SLC6A2MAPK14IMPDH2MKNK1HSD17B1 | |
| SCHEMBL21885090 | 0.91 | TSPO (0.35) | HSD17B1HSD17B2MAPTKMT2ATSPO | |
| SCHEMBL21885038 | 0.91 | TSPO (0.35) | HSD17B1HSD17B2MAPTKMT2ATSPO | |
| SCHEMBL21885105 | 0.90 | TSPO (0.36) | HSD17B1HSD17B2KMT2ATSPO | |
| SCHEMBL21885035 | 0.90 | TSPO (0.36) | HSD17B1HSD17B2KMT2ATSPO | |
| SCHEMBL21885030 | 0.89 | TSPO (0.32) | MAPK14TSPO | |
| SCHEMBL21885106 | 0.89 | TSPO (0.32) | MAPK14TSPO | |
| SCHEMBL20363824 | 0.87 | TSPO (0.36) | HSD17B1HSD17B2MEN1MAPTKMT2A | |
| SCHEMBL21885332 | 0.86 | TSPO (0.38) | HSD17B1HSD17B2MAPTKMT2ATSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20200106022-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200106022-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MAOA, PNMT, TPH1 | SLC6A2 178/4885MAPK14 2051/4885IMPDH2 401/4885 |
| US-11737355-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | MAOA, PNMT, TPH1 | SLC6A2 178/4885MAPK14 2051/4885IMPDH2 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.